Abstract
Chronic renal failure and dialysis belong to contraindications to vaccination with live vaccines. The objective of this study was to evaluate the humoral response to influenza vaccination consisting of the formation of antibodies against hemagglutinin and neuraminidase in patients undergoing chronic hemodialysis due to chronic renal failure. The study included 173 patients treated at a dialysis station in the Silesian region in Poland. The patients were assigned to the following groups: Group A-71 hemodialysis patients, mean age 65.4 ± 14.5 years; mean time of dialysis therapy 38.9 ± 31.7 months, vaccinated against influenza; Group B-39 hemodialysis patients, mean age 64 ± 13.5 years; mean time of dialysis therapy 45.0 ± 45.2 months, not vaccinated against influenza; and Group C-63 healthy patients, mean age 44.1 ± 21.2 years, vaccinated against influenza – control group. The vaccinated patients (Groups A & C) received a single dose of Agrippal influenza vaccine (Novartis) containing hemagglutinin from three strains of the influenza virus: A/Brisbane/59/2007 (H1N1), A/Brisbane/10/2007 (H3N2), and B/Brisbane/60/2008. The serological response to vaccination was assessed from antihemagglutinin (anti-HA) and antineuraminidase antibody assays (anti-NA). We found that the protection level of antibodies (protection rate) against H1 was only 40% among the vaccinated hemodialysis patients, as opposed to 65% in controls. The level of anti-H3 antibodies was similar in both groups of vaccines; 68% in dialysis patients and 75% in controls. The level of anti-HB antibodies was higher in the dialysis patient than in controls; 70% vs. 38%, respectively. The response rate to H1 antigen a month after vaccination was almost twice lower in the hemodialysis patients than in healthy controls vaccinated against influenza; 37% vs. 65%, respectively. We conclude that there is a rather insufficient serological response in the group of hemodialysis patients vaccinated with a single dose of influenza vaccine.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Advisory Committee on Immunization Practices. (2001). Prevention and control of influenza. MMWR (Morbidity and mortality weekly report), 50, 1–46.
Antonen, J. A., Hannula, P. M., Pyhälä, R., Saha, H. H., Ala-Houhala, I. O., & Pasternack, A. I. (2000). Adequate seroresponse to influenza vaccination in dialysis patients. Nephron, 86(1), 56–61.
Beyer, W. E., Versluis, D. J., Kramer, P., Diderich, P. P., Weimar, W., & Masurel, N. (1988). Trivalent influenza vaccine in patients on haemodialysis: Impaired seroresponse with differences for A-H3N2 and A-H1N1 vaccine components. Nephron, 49(1), 16–19.
Brydak, L. B., & Machala, M. (2000). Humoral immune response to influenza vaccination in patients from high risk groups. Drugs, 60(1), 35–53.
Brydak, L. B., Roszkowska-Blaim, M., Machala, M., Leszczyńska, B., & Sieniawska, M. (2000). Antibody response to influenza immunization in two consecutive epidemic seasons in patients with renal diseases. Vaccine, 18(28), 3280–3286.
Brydak, L. B., Roszkowska-Blaim, M., Machala, M., Leszczyńska, B., & Sieniawska, M. (2001). Immunological response to influenza vaccination in children with renal failure. Nephrology, Dialysis, Transplantation, 16(3), 643–644.
Cappel, R., Van Beers, D., Liesnard, C., & Dratwa, M. (1983). Impaired humoral and cell-mediated immune responses in dialyzed patients after influenza vaccination. Nephron, 33, 21–25.
Cavdar, C., Sayan, M., Sifil, A., Artuk, C., Yilmaz, N., Bahar, H., & Camsari, T. (2003). The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients. Scandinavian Journal of Urology and Nephrology, 37(1), 71–76.
Gilbertson, D. T., Unruh, M., McBean, A. M., Kausz, A. T., Snyder, J. J., & Collins, A. J. (2003). Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney International, 63(2), 738–743.
Janus, N., Vacher, L.-V., Karie, S., Ledneva, E., & Deray, G. (2008). Vaccination and chronic kidney disease. Nephrology, Dialysis, Transplantation, 23, 800–807.
Jordan, M. C., Rousseau, W. E., Tegtmeier, G. E., Noble, G. R., Muth, R. G., & Chin, T. D. (1973). Immunogenicity of inactivated influenza virus vaccine in chronic renal failure. Annals of Internal Medicine, 79(6), 790–794.
Nikoskelainen, J., Väänänen, P., Forsström, J., & Kasanen, A. (1982). Influenza vaccination in patients with chronic renal failure. Scandinavian Journal of Infectious Diseases, 14(4), 245–251.
Wyzgal, J., Brydak, L. B., Zygier, D., Paczek, L., Rowinski, W., & Grochowiecki, T. (2002). Study on efficacy of influenza vaccination in renal allograft recipients. Transplantation Proceedings, 34(2), 572–575.
Acknowledgments
Supported by a research fellowship within the ‘Development program of Wroclaw Medical University’ funded by the European Social Fund, Human Capital, National Cohesion Strategy no. UDA-POKL.04.01.01-00-010/08-01.
Conflicts of interest: The authors declared no conflicts of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this paper
Cite this paper
Mastalerz-Migas, A., Steciwko, A., Brydak, L.B. (2013). Immune Response to Influenza Vaccine in Hemodialysis Patients with Chronic Renal Failure. In: Pokorski, M. (eds) Respiratory Regulation - The Molecular Approach. Advances in Experimental Medicine and Biology, vol 756. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4549-0_35
Download citation
DOI: https://doi.org/10.1007/978-94-007-4549-0_35
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-4548-3
Online ISBN: 978-94-007-4549-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)